Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...

Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

On Friday, RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company currently trading at $96.34, downgrading the stock from Outperform ...

LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...

Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa® System - the ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...

Today we will run through one way of estimating the intrinsic value of Cochlear Limited (ASX:COH) by estimating the company's future cash flows and discounting them to their present value. We will use ...

SYDNEY & EINDHOVEN, Netherlands--(BUSINESS WIRE)--Cochlear Limited, Australian based world leader in Implantable Hearing Solutions, and NXP Semiconductors announced today that they have signed an ...

The Cochlear Ltd (ASX: COH) share price has struggled to regain momentum after a difficult year. The ASX healthcare stock finished Friday down 0.3% at $263.24. That is above its late-December low, but ...